KDM6B and colonic neoplasm: JMJD3 mediates the induction of a highly adhesive epithelial phenotype, the antiproliferative effect, the gene regulatory action, and the antagonism of the Wnt/β-catenin pathway promoted by 1,25(OH)2D3 in human colon cancer cells [66].